
Influx Healthtech Limited IPO
NSE SMEOffer Date: Jun 18, 2025 - Jun 20, 2025
Exp. Premium: 32-35 (33.33%)
₹ 115200 /1200 Shares
*Expected Premium provided in this app is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.
18 Jun, 2025
Open Date20 Jun, 2025
Close Date23 Jun, 2025
Allotment Date25 Jun, 2025
Listing DateIssue Price
₹91-96 per equity shareFace Value
₹10 Per Equity ShareListing at Group
NSE SMERegistrar
Maashitla Securities Private LimitedMarket Lot
1200 Shares (₹115,200/-)Lead Manager
Rarever Financial Advisors Pvt. LtdIssue Size
61,00,800 shares(aggregating up to ₹58.56 Cr)Retail Portion
35%Subscription
N/A timesInflux Healthtech IPO Details
Influx Healthtech Limited IPO is an SME IPO, priced at ₹91-96 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform. The IPO comprises a total issue of 61,00,800 equity shares, aggregating up to ₹58.56 crores..
The IPO bidding window is open from Jun 18, 2025 to Jun 20, 2025. The allotment is expected to be finalized on Jun 23, 2025, and the tentative listing date is Jun 25, 2025.
The minimum lot size for retail investors is 1200 shares, with a minimum investment of ₹1,15,200. For HNIs, the minimum application size is 2 lots , amounting to ₹ 2,30,400.
Rarever Financial Advisors Pvt. Ltd. is acting as the lead manager to the issue. The registrar of the IPO is Maashitla Securities Private Limited, and
Influx Healthtech Valuations
EPS Pre IPO
₹7.36/-EPS Post IPO
₹5.77/-P/E Pre IPO
13.04P/E Post IPO
16.63ROE
36.98%ROCE
49.17%Debt/Equity
0.01RoNW
36.98%PAT Margin
12.75Price to Book Value
7.62Influx Healthtech Company Financials All values are in ₹ Cr.
31-Mar-25 | 31-Mar-23 | 31-Mar-22 | |
---|---|---|---|
Assets | 70.30 | N/A | N/A |
Revenue | 104.99 | N/A | N/A |
Profit After Tax | 13.37 | N/A | N/A |
Net Worth | 36.15 | N/A | N/A |
Reserves & Surplus | 18.00 | N/A | N/A |
Total Borrowing | 0.22 | N/A | N/A |
About The Company
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-centric company dealing in contract manufacturing. The company is a trusted CDMO offering specialized services to clients in various industries. The company has three manufacturing plants in Thane, Maharashtra, each with an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.
Product Portfolio:
Tablets, Capsules, and Powders
Liquid Orals and Softgels
Lozenges, Jellies, and Gummies
Oral Dispersible Films (ODFs)
Effervescent Tablets and Liquid-Fill Capsules
Candies and Gym/Sports Supplements
Skin Care and Body Care Products
Hair Care and Beard Care Solutions
Face Masks and Soaps.
Ayurvedic / Herbal formulations
Veterinary Feed Supplements
Homecare solutions
The Company assists Nutraceutical and Cosmetic companies with product development and manufacturing. It provides end-to-end solutions, from development to production and regulatory affairs, allowing customers to concentrate on formulation and commercialization.
As of June 11, 2025, there are 163 permanent employees on the payroll of the company.
Influx Healthtech - Promoter(s)
Pre Issue Share Holding: 99.85%
Post Issue Share Holding: 73.53%
- Mr. Munir Abdul Ganee Chandniwala
- Mrs. Shirin Munir Ahmed Chandniwala
- Mr. Abdul Ganee Abdul Rasul Chandniwala.
Influx Healthtech IPO - Issue Objectives
- Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
- Purchase of Machineries for Homecare and Cosmetic Division
- General corporate purposes
Other Details
Influx Healthtech
109, Ghanshyam Enclave Premises Co-op, Soc Plot No. 856, Laljipada, Kandivali West, Mumbai, Maharashtra 400067Maashitla Securities Private Limited
Phone: +91-11-45121795-96
Email: Investor.ipo@maashitla.com
Website: https://maashitla.com/allotment-status/public-issues
Influx Healthtech IPO - FAQs
Ans. Influx Healthtech Limited IPO is a SME IPO. The issue is priced at ₹91-96 per equity share. The minimum order quantity is 1200 Shares. The IPO opens on Jun 18, 2025, and closes on Jun 20, 2025. Maashitla Securities Private Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Ans. The Influx Healthtech Limited IPO opens on Jun 18, 2025 and closes on Jun 20, 2025.
Ans. The size of Influx Healthtech Limited IPO is 61,00,800 shares(aggregating up to ₹58.56 Cr).
Ans. The IPO price band is set between ₹91-96 per equity share.
Ans. To apply for Influx Healthtech Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Influx Healthtech Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Influx Healthtech Limited IPO is Jun 23, 2025.
Ans. The Influx Healthtech Limited IPO will be listed on Jun 25, 2025.
Ans. Follow the steps to check the allotment status for Influx Healthtech Limited IPO here.